The microdomains of dormant tumors contained accumulations of myeloid and lymphoid immune cells and this microdomain modulation is complemented by resistance of the tumor cells to NK cell-mediated killing via CD200-CD200R1 interactions. This evidence concerns the gene CD200R1 and neoplasm.